Needham initiated coverage of Philip Morris International (NYSE:PM) on Thursday with a Buy rating. Analyst Gerald Pascarelli ...

Philip Morris Company OverviewZacks Rank #1 (Strong Buy) stock Philip Morris International (PM) is an international ...

Tobacco company Philip Morris International (NYSE:PM) will be reporting earnings tomorrow before market open. Here’s what investors should know. Philip Morris beat analysts’ revenue ...

Philip Morris International ( NYSE: PM) shares clocked seven straight sessions of gains, as the stock moved 0.4% higher at ...

Philip Morris (PM) thrives with smoke-free innovations like IQOS and Zyn, driving $15B in revenue and gaining investor confidence. See more here.

Below, we take a look at Philip Morris (PM), a company that currently holds a Momentum Style Score of B. We also talk about price change and earnings estimate revisions, two of the main aspects of ...

Three years after raising health groups’ suspicions by acquiring Vectura, a British pharmaceutical firm that makes asthma inhalers, cigarette giant Philip Morris International has made a deal to ...

Philip Morris' strong 2024 results, highlighted by 10% organic revenue growth and 9% adjusted EPS growth, was driven by its reduced-risk products. Smoke-free revenue grew 17% organically and gross ...

Altria and Philip Morris share a history and sell the same brands, but in different parts of the world. Philip Morris has entered the U.S. market, competing with Altria in non-cigarette businesses.

Sept 17 (Reuters) - Philip Morris International's (PM.N), opens new tab Vectura Fertin Pharma said on Tuesday it would sell its asthma inhaler maker Vectura Group to Molex Asia Holdings for 150 ...

Philip Morris International said Tuesday it is planning to invest $600 million to open a manufacturing plant in Colorado to keep up with steep demand for Zyn nicotine pouches. The tobacco giant ...